Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High Cholesterol

Mise à jour : Il y a 4 ans
Référence : NCT00145574

Femme et Homme

Extrait

This study will evaluate the lipid-lowering effect and safety of colesevelam therapy administered to heterozygous familial pediatric patients 10 through 17 years of age who are on a stable dose of a pediatric-approved statin monotherapy (atorvastatin, lovastatin, simvastatin or pravastatin), or who are treatment naive to lipid-lowering therapy.


Critère d'inclusion

  • Hypercholesterolemia


Liens